| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/20/21 | 8-K | Current report filing |
|
   |
75 |
| 12/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/08/21 | 8-K | Current report filing |
|
|
3 |
| 11/24/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/17/21 | 8-K | Current report filing |
|
|
6 |
| 11/16/21 | 8-K | Current report filing |
|
|
15 |
| 11/10/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
99 |
| 11/10/21 | 8-K | Current report filing |
|
|
7 |
| 10/15/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/12/21 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
3 |
Financials & Filings
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Graphite Bio, its subsidiaries or affiliates. No use of any Graphite Bio trademark, trade name, or trade dress in this site may be made without the prior written authorization of Graphite Bio, except to identify the product or services of the company.
©Copyright 2021 Graphite Bio, Inc. All rights reserved.